abstract |
The present invention relates to anti-OX40L antibodies, in particular anti-OX40L antibodies and variants thereof which contain an Fc portion of human origin and which do not bind to complement factor C1q. The antibodies have novel progressive properties that benefit the patients suffering from inflammatory diseases.n n n n Anti-OX40L antibody |